Daisue Construction Co., Ltd. (TYO:1814)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	24,707	19,361	17,417	12,187	13,156	10,011
Market Cap Growth	11.16%	11.16%	42.91%	-7.37%	31.42%	24.80%
Enterprise Value	23,452	19,018	10,680	6,972	5,698	-899
Last Close Price	2365.00	1853.00	1572.18	1050.66	1078.71	778.89
PE Ratio	11.98	9.40	14.10	9.23	7.25	6.25
PS Ratio	0.28	0.22	0.22	0.17	0.19	0.18
PB Ratio	1.07	0.84	0.77	0.57	0.64	0.52
P/TBV Ratio	1.18	0.92	0.93	0.57	0.64	0.53
P/FCF Ratio	-	-	-	3.32	6.99	-
P/OCF Ratio	-	-	-	2.91	6.71	-
EV/Sales Ratio	0.26	0.21	0.14	0.10	0.08	-
EV/EBITDA Ratio	5.43	4.40	5.61	3.47	2.00	-
EV/EBIT Ratio	6.35	5.15	6.71	3.70	2.10	-
EV/FCF Ratio	-6.31	-	-	1.90	3.03	-
Debt / Equity Ratio	0.14	0.14	0.21	0.01	0.02	0.03
Debt / EBITDA Ratio	0.74	0.74	2.46	0.10	0.13	0.21
Debt / FCF Ratio	-	-	-	0.06	0.20	-
Asset Turnover	1.55	1.55	1.49	1.52	1.56	1.38
Inventory Turnover	91.19	91.19	60.95	43.57	53.04	53.16
Quick Ratio	1.67	1.67	1.54	1.71	1.61	1.78
Current Ratio	1.72	1.72	1.58	1.80	1.67	1.85
Return on Equity (ROE)	9.05%	9.05%	5.60%	6.27%	9.14%	8.72%
Return on Assets (ROA)	4.03%	4.03%	1.90%	2.50%	3.79%	3.38%
Return on Capital (ROIC)	8.65%	8.65%	4.06%	5.52%	8.34%	7.29%
Return on Capital Employed (ROCE)	13.40%	13.40%	5.60%	8.00%	11.80%	10.30%
Earnings Yield	8.34%	10.64%	7.09%	10.84%	13.80%	16.01%
FCF Yield	-15.03%	-19.18%	-12.66%	30.11%	14.31%	-31.72%
Dividend Yield	4.57%	-	4.45%	-	5.56%	5.14%
Payout Ratio	39.81%	39.81%	57.98%	55.03%	22.85%	26.01%
Buyback Yield / Dilution	-0.35%	-0.35%	0.64%	0.19%	0.07%	-0.15%
Total Shareholder Return	4.28%	-0.35%	5.09%	0.19%	5.63%	4.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.